Daily Morning Note – 02 May 2018


Register HERE for MONDAY’s 11.15am webinar if you have not already done so.

Archived webinars available.


DBS Group Holdings Ltd – ROE at multi-year highs
Recommendation: Accumulate (Downgraded), Last Close Price: S$30.84
Target Price: S$32.70, Analyst: Phillip Research Team
– 1Q18 PATMI was in-line with expectations (after excluding S$86mn disposal gain)
– The standout performers were group NIMs, wealth management and Hong Kong
– Growth momentum in NII provides sustainability and visibility in earnings. ROE
was 12.5% excluding disposal gain.
– We raised our target price to S$32.70 (previously S$29.30). Our rating has been
downgraded to ACCUMULATE due to the share price performance.

Micro-Mechanics (Holdings) Ltd – Healthy growth against aggressive expectations
Recommendation: Buy (Upgraded), Last Close Price: S$1.82
Target Price: S$2.30, Analyst: Soh Lin Sin
– 3Q18 revenue and PATMI fell short of our expectations. We are trimming our
earnings forecast by 10% for FY18e.
– Margins were hurt by higher cost in capacity expansion and accounting changes.
– In line with our lower earnings forecast, our target price is lowered to S$2.30
(previously S$2.50). We are upgrading to BUY after the recent share price

Sheng Siong Group – Expansion mode on, not stopping at 50
Recommendation: Accumulate (Downgraded), Last Close Price: S$1.01
Target Price: S$1.13, Analyst: Soh Lin Sin
– 1Q18 Revenue/PATMI met 26.6%/25.3% of our full year estimations
– Earnings growth driven by new stores contribution, tailwinds from favourable
macro backdrop and improving gross margin
– Reaching its 50 stores target by 1H18 from current 48 stores; Will continue to
expand its outlet network to grab market share
– Downgraded to ACCUMULATE on recent stock price run-up; TP unchanged at

Raffles Medical Group – Sign of stronger pulse
Recommendation: Accumulate (Maintained), Last Close Price: S$1.15
Target Price: S$1.32, Analyst: Soh Lin Sin
– 1Q18 Revenue/PATMI met 23.5%/23.1% of our full year expectations
– Stronger performance on uptick in private healthcare service demand in 1Q18
– New capacities in Singapore and China to meet growing regional healthcare needs
– Maintained Accumulate with unchanged TP of S$1.32


China Everbright Ltd – Daily timeframe – Bullish
– The recent bullish price action is signalling for a near-term bottoming price action
next with a bullish break above the 0.405 range high on 30/04/18 with increasing
– Expect a reversal higher next for price to test the 0.460 resistance area followed
by 0.490.

For more information and additional disclosures, refer to the link here.


Wall Street rises on optimism on NAFTA deal and China trade. The Nasdaq composite advanced 0.91% to end at 7,190.70 as Apple stock jumped ahead of expectation-topping results released after the market close, and the S&P 500 gained 0.25% to close at 2,654.80. The Dow Jones industrial average, however, slipped 0.27% to finish the session at 24,099.05. Almost 80% of S&P 500 companies that had reported first-quarter results as of Monday had topped expectations.

The dollar’s rally continued, with the greenback posting its biggest advance in more than a week as it breached a number of key resistance levels. The dollar, traded against a basket of major currencies, rose as high as 92.566, the highest since Jan 10, before retracing to 92.454. The greenback is approaching this year’s high of 92.64 reached on Jan 9. and is above the year’s open at 92.24. The currency’s strength weighed on commodities, with oil retreating and gold headed for the lowest since December.

U.S. Commerce Secretary Wilbur Ross said on Tuesday that the Trump administration was prepared to levy tariffs on China if an American delegation heading to Beijing did not reach a negotiated settlement to reduce trade imbalances.

Apple reported revenue and profit that beat analysts’ estimates and projected continued sales momentum, calming concern about demand for the iPhone. The Cupertino, California-based company also unveiled a new plan to return more money to shareholders and said services sales jumped 31%.

The Reserve Bank of Australia left its cash rate unchanged at 1.5 percent in a widely anticipated move.

The London Stock Exchange’s clearing arm LCH has begun clearing interest rate swaps denominated in yuan, won and rupees to bolster its Asia base as euro business faces the threat of relocation. LCH has begun clearing non-deliverable rate swaps in the three Asian currencies for the first time, pitting it more directly against rival clearers like the Singapore Exchange.

Addvalue Technologies is raising up to S$10 million through a stock placement of 250 million shares at four Singapore cents apiece, the satellite communications company.

Australian energy company AusNet Services will be delisting from the Singapore Exchange (SGX) after 13 years.

SPH Reit has agreed to acquire The Rail Mall for S$63.24 million, in a transaction expected to be funded by a combination of debt and internal resources.

Procurri will not be raising any equity this year as its major shareholder DeClout has blocked it from renewing a mandate to issue and allot new shares.

Source: Bloomberg, Channel NewsAsia, The Business Times, SGX Masnet, Reuters, PSR

Clients of Phillip Securities can keep updated with Country Strategy and Singapore Sector Reports by logging into: www.poems.com.sg > STOCKS > Research

Read the research report(s), available through the link(s) above, for complete information including important disclosures

Important Information

The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided “as is” without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Confidentiality Note
This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.


Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com